Angiodynamics Inc (ANGO) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2026, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Angiodynamics Inc   (NASDAQ: ANGO)
 

Angiodynamics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Angiodynamics Inc inventory turnover ratio, the Angiodynamics Inc 's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 2.47 in the first quarter 2026, yet the ratio remained below the average, as ANGO's market remain challenging.Average inventory processing period, for the Angiodynamics Inc in Aug 31 2026 quarter, has decreased to 148 days, compare to 153 days, in the May 31 2026 quarter.

Within Healthcare sector 157 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2026, to 1481, from total ranking in the fourth quarter 2026 at 1693.

ANGO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Angiodynamics Inc Market Share?

What is Inventory Turnover Ratio?




ANGO Inventory Turnover Ratio (Aug 31 2026)
I. Quarter
(May 31 2026)
IV. Quarter
(Feb 28 2026)
III. Quarter
(Nov 30 2025)
II. Quarter
(Aug 31 2025)
I. Quarter
Y / Y Inventory Growth -11.73 % -15.43 % -7.17 % -0.53 % -3.78 %
Y / Y Cost of Sales Growth -0.38 % 2.14 % 9.09 % 6.25 % 10 %
Inventory Turnover Ratio (TTM) 2.47 2.39 2.29 2.2 2.16
ANGO's Total Ranking # 1481 # 1693 # 1538 # 1563 # 1763
Average inventory processing period 148 153 160 166 169
Seq. Inventory Growth 4.8 % -10.49 % -10.66 % 5.32 % 0.4 %
Seq. Cost of Sales Growth -17.47 % 10.65 % 5.88 % 3.03 % -15.38 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 64
Healthcare Sector # 158
Overall Market # 1481

Inventory Turnover Ratio Statistics
High Average Low
3.25 2.47 1.11
(May 31 2018)   (Nov 30 2024)




Financial Statements
Angiodynamics Inc 's Inventories $ 55 Millions Visit ANGO's Balance sheet
Angiodynamics Inc 's Cost of Revenues TTM $ 143 Millions Visit ANGO's Income Statement
What are ANGO's Sales? Visit ANGO's Sales by Segment

Other Inventory Turnover Ratios
Angiodynamics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ANGO's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ANGO's Competitors
Inventory Turnover Ratio for ANGO's Suppliers
Inventory Turnover Ratio for ANGO's Customers

You may also want to know
ANGO's Sales Growth Rates ANGO's Pe Price to earnings ratio ANGO's Receivables Turnover Ratio ANGO's Stock Quote
ANGO's Net Income Growth Rates ANGO's Ps Price to Sales ratio ANGO's Sales per Employee ANGO's Asset Turnover Ratio
ANGO's Net Margin ANGO's Pb Price to Book ratio ANGO's Financial Strength Ratios ANGO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Aug 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Aug 31 2026 Inventories at quarter ending Aug 31 2026
Novavax inc   7.03 $ 90.533  Millions$ 13  Millions
Carlisle Companies Incorporated  6.99 $ 3,406.400  Millions$ 488  Millions
Caredx Inc   6.42 $ 111.106  Millions$ 17  Millions
Edap Tms Sa  6.14 $ 60.833  Millions$ 10  Millions
Transmedics Group Inc   5.70 $ 301.220  Millions$ 53  Millions
Bristol myers Squibb Company  5.65 $ 15,389.000  Millions$ 2,722  Millions
Avantor Inc   5.48 $ 4,539.200  Millions$ 828  Millions
Tactile Systems Technology Inc   5.25 $ 82.718  Millions$ 16  Millions
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Cryoport inc   4.60 $ 102.157  Millions$ 22  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions
Exelixis Inc   3.49 $ 93.324  Millions$ 27  Millions
Abbvie Inc   3.40 $ 17,346.000  Millions$ 5,108  Millions
Gilead Sciences Inc   3.30 $ 6,219.000  Millions$ 1,884  Millions
Iovance Biotherapeutics inc   3.21 $ 177.232  Millions$ 55  Millions
Teva Pharmaceutical Industries Limited  3.16 $ 8,011.000  Millions$ 2,537  Millions
Msa Safety Inc  3.00 $ 1,063.235  Millions$ 354  Millions
Mimedx Group Inc   2.98 $ 70.562  Millions$ 24  Millions
Abbott Laboratories  2.95 $ 20,765.000  Millions$ 7,032  Millions
Ligand Pharmaceuticals Incorporated  2.93 $ 34.495  Millions$ 12  Millions
Zai Lab Limited  2.91 $ 200.083  Millions$ 69  Millions

Date modified: 2026-10-09T04:24:09+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.